Literature DB >> 3522428

Bactericidal action of eosinophils from normal human blood.

M Yazdanbakhsh, C M Eckmann, A A Bot, D Roos.   

Abstract

The ability of normal human eosinophils to ingest and kill Staphylococcus aureus and Escherichia coli was investigated and compared with the reactions shown by neutrophils from the same donors. The rate of phagocytosis of S. aureus by eosinophils was 50% of that shown by neutrophils. Unlike neutrophils, eosinophils were not able to kill ingested S. aureus at low bacterium/phagocyte ratios. The degree of S. aureus killing increased with increasing ratios, being equal to that of neutrophils when bacterium/phagocyte ratios of about 15 were used. This was probably due to a better triggering of the eosinophil oxidase system at high bacterium/phagocyte ratios. The early kinetics of the association of bacteria with eosinophils, the perforation of the bacterial envelope and the inactivation of bacterial proteins, was monitored in the ML-35 mutant strain of E. coli. The association of E. coli with eosinophils was 70% of that with neutrophils. Eosinophils had only 25% of the capacity of neutrophils to perforate the E. coli envelope. E. coli loses its colony-forming ability when the bacterial envelope has been perforated, indicating that eosinophils also kill E. coli more slowly than do neutrophils. This was confirmed with a plating assay for colony formation. The perforation of E. coli is independent of peroxidase-mediated reactions. Hence, the defective bactericidal action of eosinophils is probably not related to the differences between myeloperoxidase and eosinophil peroxidase. On the other hand, the inactivation of bacterial proteins is peroxidase dependent and was also seen to occur to a lesser extent in eosinophils compared with neutrophils. We conclude that eosinophils ingest E. coli but only slowly perforate (kill) these bacteria and barely inactivate the bacterial enzymes. In contrast, neutrophils quickly ingest and perforate (kill) E. coli and quickly inactivate the bacterial enzymes.

Entities:  

Mesh:

Year:  1986        PMID: 3522428      PMCID: PMC260096          DOI: 10.1128/iai.53.1.192-198.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Eosinophils as mediators of antibody-dependent damage to schistosomula.

Authors:  A E Butterworth; R F Sturrock; V Houba; A A Mahmoud; A Sher; P H Rees
Journal:  Nature       Date:  1975-08-28       Impact factor: 49.962

2.  Oxidative metabolism of the human eosinophil.

Authors:  L R DeChatelet; P S Shirley; L C McPhail; C C Huntley; H B Muss; D A Bass
Journal:  Blood       Date:  1977-09       Impact factor: 22.113

3.  Protection of phagocytic leukocytes by endogenous glutathione: studies in a family with glutathione reductase deficiency.

Authors:  D Roos; R S Weening; A A Voetman; M L van Schaik; A A Bot; L J Meerhof; J A Loos
Journal:  Blood       Date:  1979-05       Impact factor: 22.113

4.  Oxygen consumption of phagocytizing cells in human leukocyte and granulocyte preparations: a comparative study.

Authors:  R S Weening; D Roos; J A Loos
Journal:  J Lab Clin Med       Date:  1974-04

5.  Metabolic and bactericidal activities of human eosinophils.

Authors:  R L Baehner; R B Johnston
Journal:  Br J Haematol       Date:  1971-03       Impact factor: 6.998

6.  Characterization of the interaction of human eosinophils and neutrophils with opsonized particles.

Authors:  M Yazdanbakhsh; C M Eckmann; D Roos
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

7.  Stage-specific antibody-dependent eosinophil-mediated destruction of Trichinella spiralis.

Authors:  J W Kazura; D I Grove
Journal:  Nature       Date:  1978-08-10       Impact factor: 49.962

8.  Comparison of intracellular bactericidal activities of human neutrophils and eosinophils.

Authors:  L R DeChatelet; R A Migler; P S Shirley; H B Muss; P Szejda; D A Bass
Journal:  Blood       Date:  1978-09       Impact factor: 22.113

9.  The mechansim of antibody-dependent, eosinophil-mediated damage to schistosomula of Schistosoma mansoni in vitro: a study by phase-contrast and electron microscopy.

Authors:  A M Glauert; A E Butterworth; R F Sturrock; V Houba
Journal:  J Cell Sci       Date:  1978-12       Impact factor: 5.285

10.  A role for the eosinophil in acquired resistance to Schistosoma mansoni infection as determined by antieosinophil serum.

Authors:  A A Mahmoud; K S Warren; P A Peters
Journal:  J Exp Med       Date:  1975-10-01       Impact factor: 14.307

View more
  14 in total

1.  Purification of eosinophils from normal human blood, preparation of eosinoplasts and characterization of their functional response to various stimuli.

Authors:  M Yazdanbakhsh; C M Eckmann; M De Boer; D Roos
Journal:  Immunology       Date:  1987-01       Impact factor: 7.397

Review 2.  The role of eosinophils in non-parasitic infections.

Authors:  Stefanie N Linch; Jeffrey A Gold
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2011-06       Impact factor: 2.895

Review 3.  Eosinophils in mucosal immune responses.

Authors:  J Travers; M E Rothenberg
Journal:  Mucosal Immunol       Date:  2015-03-25       Impact factor: 7.313

4.  Bactericidal activity of human eosinophilic granulocytes against Escherichia coli.

Authors:  T Persson; P Andersson; M Bodelsson; M Laurell; J Malm; A Egesten
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

Review 5.  The regulatory role of eosinophils in viral, bacterial, and fungal infections.

Authors:  Pratibha Gaur; Ilan Zaffran; Tresa George; Fidan Rahimli Alekberli; Micha Ben-Zimra; Francesca Levi-Schaffer
Journal:  Clin Exp Immunol       Date:  2022-07-22       Impact factor: 5.732

6.  Distinct endocytic mechanisms of CD22 (Siglec-2) and Siglec-F reflect roles in cell signaling and innate immunity.

Authors:  Hiroaki Tateno; Hongyi Li; Melissa J Schur; Nicolai Bovin; Paul R Crocker; Warren W Wakarchuk; James C Paulson
Journal:  Mol Cell Biol       Date:  2007-06-11       Impact factor: 4.272

Review 7.  Eosinophils in infection and intestinal immunity.

Authors:  Simon P Hogan; Amanda Waddell; Patricia C Fulkerson
Journal:  Curr Opin Gastroenterol       Date:  2013-01       Impact factor: 3.287

8.  The Systemic Immune Response in COVID-19 Is Associated with a Shift to Formyl-Peptide Unresponsive Eosinophils.

Authors:  Leo Koenderman; Maarten J Siemers; Corneli van Aalst; Suzanne H Bongers; Roy Spijkerman; Bas J J Bindels; Giulio Giustarini; Harriët M R van Goor; Karin A H Kaasjager; Nienke Vrisekoop
Journal:  Cells       Date:  2021-05-05       Impact factor: 6.600

9.  The presence of eosinophil leucocytes in cervicovaginal smears with Actinomyces-like organisms: Light microscopic examination.

Authors:  Dilek Kaya; Sayeste Demirezen; Mehmet Sinan Beksaç
Journal:  J Cytol       Date:  2012-10       Impact factor: 1.000

Review 10.  Eosinophils and Bacteria, the Beginning of a Story.

Authors:  Edna Ondari; Esther Calvino-Sanles; Nicholas J First; Monica C Gestal
Journal:  Int J Mol Sci       Date:  2021-07-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.